Immuno-Haematological Abnormalities of HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Therapy in the Antiretroviral Therapy Clinics of Six Health Facilities at Dessie Town, Northeast Ethiopia

References

• Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. Aids. 2009;23(2):147–160. doi:10.1097/QAD.0b013e3283217f9f
   PubMed Web of Science ®Google Scholar
• Rudnicka D, Schwartz O. Intrusive HIV-1-infected cells. Nat Immunol. 2009;10(9):933–934. doi:10.1038/ni0909-933
   PubMed Web of Science ®Google Scholar
• Wamala K, Nuwamanya R, Muwanga M. Prevalence of HIV and associated risk factors among infants born to HIV positive mothers attending Entebbe regional referral hospital. SJHR Africa. 2021;2(3):11.
   Google Scholar
• Worku ED, Asemahagn MA, Endalifer ML. Epidemiology of HIV infection in the Amhara region of Ethiopia, 2015 to 2018 surveillance data analysis. HIV/AIDS. 2020;12:307.
   Google Scholar
• Anastos K, Shi Q, French AL, et al. Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1–infected women receiving highly active antiretroviral therapy. JAIDS. 2004;35(4):383–392. doi:10.1097/00126334-200404010-00008
   Web of Science ®Google Scholar
• Gunda DW, Godfrey KG, Kilonzo SB, Mpondo BC. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: a crosssectional study. Malawi Med J. 2017;29(1):43–52. doi:10.4314/mmj.v29i1.9
   PubMed Web of Science ®Google Scholar
• Scaradavou A. HIV-related thrombocytopenia. Blood Rev. 2002;16(1):73–76. doi:10.1054/blre.2001.0188
   PubMed Web of Science ®Google Scholar
• Opie J. Haematological complications of HIV infection: forum-review. S Afr Med J. 2012;102(6):465–468. doi:10.7196/SAMJ.5595
   PubMed Web of Science ®Google Scholar
• Shiferaw MB, Endalamaw D, Hussien M, et al. Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia. BMC Infect Dis. 2019;19(1):1–6. doi:10.1186/s12879-019-4058-4
   PubMed Web of Science ®Google Scholar
• Durandt C, Potgieter J, Khoosal R, et al. HIV and haematopoiesis. S Afr Med J. 2019;109(8 Supplement 1):S41–S6. doi:10.7196/SAMJ.2019.v109i8b.13829
   PubMed Web of Science ®Google Scholar
• Enawgaw B, Alem M, Addis Z, Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC Hematol. 2014;14(1):1–7.
   Google Scholar
• Firnhaber C, Smeaton L, Saukila N, et al. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis. 2010;14(12):e1088–e1092. doi:10.1016/j.ijid.2010.08.002
   PubMed Web of Science ®Google Scholar
• Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia. Blood. 2005;106(2):572–576. doi:10.1182/blood-2005-01-0243
   PubMed Web of Science ®Google Scholar
• Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Brief report: risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;52(5):595. doi:10.1097/QAI.0b013e3181b79aff
   PubMed Web of Science ®Google Scholar
• Alexaki A, Wigdahl BHIV-1. infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog. 2008;4(12):e1000215. doi:10.1371/journal.ppat.1000215
   PubMed Web of Science ®Google Scholar
• Wondimeneh Y, Muluye D, Ferede G. Prevalence and associated factors of thrombocytopenia among HAART naive HIV positive patients at Gondar University Hospital, northwest Ethiopia. BMC Res Notes. 2014;7(1):1–4. doi:10.1186/1756-0500-7-5
   PubMedGoogle Scholar
• Akinbami A, Oshinaike O, Adeyemo T, et al. Hematologic abnormalities in treatment-naive HIV patients. Infect Dis. 2010;3(IDRT):S6033.
   Google Scholar
• Oudatzis G, Tsagarakis NJ, Paterakis G, et al. Evaluation of automated capillary complete blood counts for routine clinical decision making in a large cohort of hematological patients, using Mindray BC‐3000 Plus Auto and Sysmex XE‐5000 hematology analyzers. Int J Lab Hematol. 2020;42(5):565–572. doi:10.1111/ijlh.13237
   PubMed Web of Science ®Google Scholar
• Tagoe DNA, Boachie J. Assessment of the impact of malaria on CD4+ T Cells and haemoglobin levels of HIV-malaria co-infected patients. J Infect Dev Ctries. 2012;6(09):660–663. doi:10.3855/jidc.2124
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Guideline on Use of Ferritin Concentrations to Assess Iron Status in Individuals and Populations; 2020.
   Google Scholar
• CHeCK Q. Eosinophilia, Leukocytosis, thrombocytopenia, thrombocytosis, Anemia, Hepatic Function Abnormalities. In: The Clozapine Handbook: Stahl’s Handbooks. Cambridge University Press; 2019.
   Google Scholar
• Fan L, Li C, Zhao H. Prevalence and risk factors of cytopenia in HIV-infected patients before and after the initiation of HAART. Biomed Res Int. 2020;2020. doi:10.1155/2020/3132589
   Web of Science ®Google Scholar
• Fekene TE, Juhar LH, Mengesha CH, Worku DK. Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study. BMC Hematol. 2018;18(1):1–11. doi:10.1186/s12878-018-0102-7
   PubMedGoogle Scholar
• Wanjari A, Acharya S, Singh AP, Rathi C. A study of hematological profile in HIV/AIDS. AIDS. 2013;8:9.
   Google Scholar
• Tesfaye Z, Enawgaw B. Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study. BMC Res Notes. 2014;7(1):1–5. doi:10.1186/1756-0500-7-745
   PubMedGoogle Scholar
• Denue BA, Kida IM, Hammagabdo A, Dayar A, Sahabi MA. Prevalence of anemia and immunological markers in HIV-infected patients on highly active antiretroviral therapy in Northeastern Nigeria. Infect Dis. 2013;6(IDRT):S10477.
   Google Scholar
• Gedefaw L, Yemane T, Sahlemariam Z, Yilma D. Anemia and risk factors in HAART naive and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS One. 2013;8(8):e72202. doi:10.1371/journal.pone.0072202
   PubMed Web of Science ®Google Scholar
• Woldeamanuel GG, Wondimu DH. Prevalence of thrombocytopenia before and after initiation of HAART among HIV infected patients at black lion specialized hospital, Addis Ababa, Ethiopia: a cross sectional study. BMC Hematol. 2018;18(1):1–6. doi:10.1186/s12878-018-0097-0
   PubMedGoogle Scholar
• Melku M, Addis Z, Alem M, Enawgaw B. Prevalence and predictors of maternal anemia during pregnancy in Gondar, Northwest Ethiopia: an institutional based cross-sectional study. Anemia. 2014;2014. doi:10.1155/2014/108593
   PubMedGoogle Scholar
• Jam S, Ramezani A, Sabzevari D, et al. A cross-sectional study of anemia in human immunodeficiency virus-infected patients in Iran; 2009.
   Google Scholar
• Amegor O, Bigila D, Oyesola O, Oyesola T, Buseni S. Hematological changes in HIV patients placed on anti retroviral therapy in Markurdi, Benue State of Nigeria. Asian J Epidemiol. 2009;2(4):97–103. doi:10.3923/aje.2009.97.103
   Google Scholar
• Harris RJ, Sterne JA, Abgrall S, et al. Prognostic importance of anaemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries. Antivir Ther. 2008;13(8):959. doi:10.1177/135965350801300802
   PubMed Web of Science ®Google Scholar
• Gebremedhin KB, Haye TB. Factors associated with anemia among people living with HIV/AIDS taking ART in Ethiopia. Adv Hematol. 2019;2019. doi:10.1155/2019/9614205
   PubMedGoogle Scholar
• De Santis GC, Brunetta DM, Vilar FC, et al. Hematological abnormalities in HIV-infected patients. Int J Infect Dis. 2011;15(12):e808–e811. doi:10.1016/j.ijid.2011.08.001
   PubMed Web of Science ®Google Scholar
• Quaye W, Addai-Mensah A. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011;11:1.
   Web of Science ®Google Scholar
• Meidani M, Rezaei F, Maracy MR, Avijgan M, Tayeri K. Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 2012;17(2):138.
   PubMed Web of Science ®Google Scholar
• Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker L-G, Lawn SD. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa. BMC Infect Dis. 2014;14(1):1–12. doi:10.1186/s12879-014-0702-1
   PubMed Web of Science ®Google Scholar
• Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA. 1990;264(12):1556–1559. doi:10.1001/jama.1990.03450120068031
   PubMed Web of Science ®Google Scholar
• Gebreweld A, Fiseha T, Girma N, Haileslasie H, Gebretsadik D. Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia. PLoS One. 2020;15(9):e0239215. doi:10.1371/journal.pone.0239215
   PubMed Web of Science ®Google Scholar
• Rezaei E, Ebrahim-Saraie HS, Heidari H, et al. Impact of vitamin supplements on HAART related hematological abnormalities in HIV-infected patients. Med J Islam Repub Iran. 2016;30:350.
   PubMedGoogle Scholar
• Huruy K, Kassu A, Mulu A, Wondie Y. Immune restoration disease and changes in CD4+ T-cell count in HIV-infected patients during highly active antiretroviral therapy at Zewditu Memorial Hospital, Addis Ababa, Ethiopia. AIDS Res Ther. 2010;7(1):1–7. doi:10.1186/1742-6405-7-46
   PubMed Web of Science ®Google Scholar
• Derbe M, Monga D, Daka D. Immunological response among HIV/AIDS patients before and after ART therapy at Zewuditu Hospital Addis Ababa, Ethiopia. Am J Res Commun. 2013;1(1):103–115.
   Google Scholar
• Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44(3):441–446. doi:10.1086/510746
   PubMed Web of Science ®Google Scholar
• Vidya Vijayan K, Karthigeyan KP, Tripathi SP, Hanna LE. Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections. Front Immunol. 2017;8:580. doi:10.3389/fimmu.2017.00580
   PubMed Web of Science ®Google Scholar
• Gautam H, Bhalla P, Saini S, Dewan R. Correlation between baseline CD4+ T-Lymphocyte count and plasma viral load in AIDS patients and their early clinical and immunological response to HAART: a preliminary study. Indian J Med Microbiol. 2008;26(3):256–258. doi:10.4103/0255-0857.42039
   PubMed Web of Science ®Google Scholar
• Patil SS, Patil VS. Correlation of blood profile and CD4 count in AIDS patients before and after HAART, Study in Western Maharashtra. Biomed Pharmacol J. 2020;13(1):101–105. doi:10.13005/bpj/1866
   Google Scholar
• Sokoya T, Steel HC, Nieuwoudt M, Rossouw TM. HIV as a cause of immune activation and immunosenescence. Mediators Inflamm. 2017;2017. doi:10.1155/2017/6825493
   PubMed Web of Science ®Google Scholar
• Duguma N, Kiya GT, Maleko WA, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: a cross-sectional study. SAGE Open Med. 2021;9:20503121211020175. doi:10.1177/20503121211020175
   Google Scholar
• Taremwa IM, Muyindike WR, Muwanguzi E, Boum Y. Prevalence of HIV-related thrombocytopenia among clients at Mbarara Regional Referral Hospital, Mbarara, southwestern Uganda. J Blood Med. 2015;6:109. doi:10.2147/JBM.S80857
   PubMedGoogle Scholar
• Getawa S, Aynalem M, Bayleyegn B, Adane T. The global prevalence of Thrombocytopenia among HIV infected adults: a systematic Review and Meta-analysis. Int J Infect Dis. 2021;105:495–504. doi:10.1016/j.ijid.2021.02.118
   PubMed Web of Science ®Google Scholar
• Nascimento FG, Tanaka PY. Thrombocytopenia in HIV-infected patients. Indian J Hematol Blood Transfus. 2012;28(2):109–111. doi:10.1007/s12288-011-0124-9
   PubMed Web of Science ®Google Scholar